APA
Yen C., Sharma R., Rimassa L., Arizumi T., Bettinger D., Choo H. Y., Pressiani T., Burlone M. E., Pirisi M., Giordano L., Abdulrahman A., Kudo M., Thimme R., Park J. W. & Pinato D. J. (2017). Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study. : Liver cancer.
Chicago
Yen Clarence, Sharma Rohini, Rimassa Lorenza, Arizumi Tadaaki, Bettinger Dominik, Choo Huay Yee, Pressiani Tiziana, Burlone Michela E, Pirisi Mario, Giordano Laura, Abdulrahman Anisa, Kudo Masatoshi, Thimme Robert, Park Joong Won and Pinato David James. 2017. Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study. : Liver cancer.
Harvard
Yen C., Sharma R., Rimassa L., Arizumi T., Bettinger D., Choo H. Y., Pressiani T., Burlone M. E., Pirisi M., Giordano L., Abdulrahman A., Kudo M., Thimme R., Park J. W. and Pinato D. J. (2017). Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study. : Liver cancer.
MLA
Yen Clarence, Sharma Rohini, Rimassa Lorenza, Arizumi Tadaaki, Bettinger Dominik, Choo Huay Yee, Pressiani Tiziana, Burlone Michela E, Pirisi Mario, Giordano Laura, Abdulrahman Anisa, Kudo Masatoshi, Thimme Robert, Park Joong Won and Pinato David James. Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study. : Liver cancer. 2017.